ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Ocean Biomedical Inc

Ocean Biomedical Inc (OCEA)

0.5246
-0.0644
( -10.93% )
更新日時: 00:50:05

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.5246
買値
0.52
売値
0.5246
出来高
8,198,851
0.4603 日の範囲 0.60
0.4603 52 週間の範囲 7.79
時価総額
前日終値
0.589
始値
0.5655
最終取引時間
00:49:09
財務取引量
US$ 4,204,225
VWAP
0.512782
平均取引量 (3 か月)
51,489
発行済株式数
34,818,628
配当利回り
-
PER
-3.03
1 株当たり利益 (EPS)
-3.29
歳入
-
純利益
-114.47M

Ocean Biomedical Inc について

Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Ocean Biomedical Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker OCEA. The last closing price for Ocean Biomedical was US$0.59. Over the last year, Ocean Biomedical shares have traded in a share price range of US$ 0.4603 to US$ 7.79.

Ocean Biomedical currently has 34,818,628 shares in issue. The market capitalisation of Ocean Biomedical is US$20.51 million. Ocean Biomedical has a price to earnings ratio (PE ratio) of -3.03.

OCEA 最新ニュース

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market...

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued a key U.S. patent...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC...

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, May 30, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on May 22, 2024, it received a notice from The Nasdaq Stock Market...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.1544-22.73932253310.6790.69990.4603513940.61963743CS
4-0.1754-25.05714285710.70.760.4603433700.67395809CS
12-0.4004-43.28648648650.9251.160.4603514890.8489448CS
26-0.8854-62.79432624111.411.690.4603677511.04594263CS
52-0.0654-11.08474576270.597.790.460317980532.95796845CS
156-9.4354-94.73293172699.9626.59860.460315810204.7377768CS
260-9.4354-94.73293172699.9626.59860.460315810204.7377768CS

OCEA - Frequently Asked Questions (FAQ)

What is the current Ocean Biomedical share price?
The current share price of Ocean Biomedical is US$ 0.5246
How many Ocean Biomedical shares are in issue?
Ocean Biomedical has 34,818,628 shares in issue
What is the market cap of Ocean Biomedical?
The market capitalisation of Ocean Biomedical is USD 20.51M
What is the 1 year trading range for Ocean Biomedical share price?
Ocean Biomedical has traded in the range of US$ 0.4603 to US$ 7.79 during the past year
What is the PE ratio of Ocean Biomedical?
The price to earnings ratio of Ocean Biomedical is -3.03
What is the reporting currency for Ocean Biomedical?
Ocean Biomedical reports financial results in USD
What is the latest annual profit for Ocean Biomedical?
The latest annual profit of Ocean Biomedical is USD -114.47M
What is the registered address of Ocean Biomedical?
The registered address for Ocean Biomedical is 8 THE GREEN, STE A, KENT, DOVER, DELAWARE, 19901
What is the Ocean Biomedical website address?
The website address for Ocean Biomedical is www.aestherhealthcarespac.com
Which industry sector does Ocean Biomedical operate in?
Ocean Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 5.32
(294.07%)
90.96M
ABPAbpro Holdings Inc
US$ 3.16
(112.08%)
3.94M
HSDTHelius Medical Technologies Inc
US$ 0.8901
(85.44%)
90.91M
NVNINVNI Group Ltd
US$ 4.326
(62.02%)
20.61M
HUMAHumacyte Inc
US$ 5.55
(60.40%)
46.04M
CYNCYNGN Inc
US$ 0.388
(-75.90%)
15.09M
MTEMMolecular Templates Inc
US$ 0.143
(-59.14%)
3.43M
GALTGalectin Therapeutics Inc
US$ 0.85
(-57.50%)
5.8M
PRFXPainReform Ltd
US$ 5.37
(-51.88%)
1.68M
BCABBioAtla Inc
US$ 0.790016
(-33.61%)
2.02M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.62
(8.77%)
142.57M
TAOPTaoping Inc BVI
US$ 0.4623
(45.84%)
121.87M
RGTIRigetti Computing Inc
US$ 8.93
(19.54%)
93.44M
HSDTHelius Medical Technologies Inc
US$ 0.8901
(85.44%)
92.47M
MYSZMy Size Inc
US$ 5.32
(294.07%)
91.99M

OCEA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock